Core One Labs Inc CLABF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.15
- Day Range
- $0.15–0.15
- 52-Week Range
- $0.12–0.50
- Bid/Ask
- $0.14 / $0.17
- Market Cap
- $6.88 Mil
- Volume/Avg
- 1,723 / 4,412
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Core One Labs Inc is a psychedelic research and development life sciences enterprise focused on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy. The company intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. The Company operates a virtual clinic that assesses patients for the appropriateness of treatment plans for the use of medical cannabis to treat their symptoms. The Company partners with physicians and Health Canada’s licensed producers for the provision of treatments, fulfillment of prescriptions, and sale of related products.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.core1labs.com
Valuation
|
Metric
|
CLABF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.63 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
CLABF
Financial Strength
|
Metric
|
CLABF
|
|---|---|
Quick Ratio | 0.22 |
Current Ratio | 0.25 |
Interest Coverage | — |
Quick Ratio
CLABF
Profitability
|
Metric
|
CLABF
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
CLABF
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Vqqhcnkxq | Gfdb | $586.5 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Lyrfbqzs | Tkcfq | $110.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Vpwpbytfb | Khwvglj | $107.8 Bil | |
MRNA
| Moderna Inc | Hwjhysf | Ltrz | $48.2 Bil | |
BNTX
| BioNTech SE ADR | Fpkdqlwf | Hxd | $22.2 Bil | |
ARGX
| argenx SE ADR | Tlvbbbmg | Qhycl | $22.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Lxbzvfcw | Rzfbttz | $18.6 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Xkfnnkprz | Vvyxn | $15.1 Bil | |
INCY
| Incyte Corp | Bfbgzfnv | Qksvhr | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Chkmnxgjdx | Jlnjn | $12.7 Bil |